EMCDDA Director Alexis Goosdeel is in Paris today where he will meet with representatives of the French Monitoring Centre for Drugs and Drug Addiction (Observatoire français des drogues et des toxicomanies/OFDT) and the Interministerial Mission for Combating Drugs and Addictive Behaviours (Mission interministérielle de lutte contre les drogues et les conduites addictives/MILDECA).
At OFDT — the French national focal point in the Reitox network— the EMCDDA Director will present the agency’s activities in the period 2018–19 under its Strategy 2025. Director of OFDT Julien Morel d’Arleux will speak on the national drug situation. The two Directors will also discuss collaboration between the agency and the focal point on projects such as the EMCDDA key epidemiological indicators and the European syringe collection and analysis project enterprise (ESCAPE).
In the afternoon, Mr Goosdeel will meet with Laura d’Arrigo, Diplomatic advisor at MILDECA and Chair of the EMCDDA Management Board. He will end the day presenting to MILDECA the new EMCDDA report launched on 4 December: Medical use of cannabis and cannabinoids: questions and answers for policymaking.